Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-69,962
Closed -$7.98M 39
2024
Q3
$7.98M Buy
69,962
+7,531
+12% +$826K 2.28% 7
2024
Q2
$6.49M Sell
62,431
-19,636
-24% -$2.08M 0.82% 12
2024
Q1
$9.33M Sell
82,067
-9,043
-10% -$1.04M 3.49% 7
2023
Q4
$10K Buy
91,110
+2,024
+2% +$202K 0.81% 6
2023
Q3
$8.63K Buy
89,086
+7,223
+9% +$759K 0.16% 7
2023
Q2
$8.93K Buy
81,863
+11,104
+16% +$1.18M 1.9% 7
2023
Q1
$7.17M Buy
70,759
+8,234
+13% +$869K 2.48% 8
2022
Q4
$6.87M Buy
+62,525
New +$6.47M 2.53% 8

Other funds holding ABT

Trium Capital's ABT Position: Q4 2024 in Review

Trium Capital sold out of Abbott (ABT) in Q4 2024, closing a stake of 69,962 shares — an estimated $7.98M sold.

Trium Capital first reported a position in ABT in Q4 2022 and held it in 8 quarters. The position peaked at $9.33M in Q1 2024. 3,066 funds tracked by Wall St. Rank hold ABT as of Q4 2024.

  • Trium Capital reported no remaining Abbott position as of Q4 2024 after selling out during the quarter.
  • Trium Capital sold 69,962 Abbott shares in Q4 2024, an estimated $7.98M.
  • Trium Capital first reported a position in Abbott in Q4 2022 and held it in 8 quarters.
  • Trium Capital's Abbott position peaked at $9.33M in Q1 2024.
  • 3,066 funds tracked by Wall St. Rank held Abbott as of Q4 2024.

Based on Trium Capital's 13F filing for Q4 2024, filed 15 Jan 2025.